Home
Conditions
Thoracic Neoplasms

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,076 public trials 1,849 recruiting studies

Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Completed

Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI Therapy

NCT04207775

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Research Site Beijing, China

Research Site Changsha, China

Research Site Chengdu, China

Research Site Chengdu, China

View all 16 locations

View Trial Details

Completed

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

NCT03091816

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)

NCT04727853

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Jilin Cancer Hospital Changchun, Jilin, China

View Trial Details

Completed

Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients

NCT04902885

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations: Jilin Cancer Hopspital Changchun, China

View Trial Details

Completed

Optimal Postoperative Pain Management After Lung Surgery (OPtriAL)

NCT05491239

Conditions: Locoregional Anaesthesia, Lung Cancer, Lung Diseases, +15 more
Locations: Maxima MC Veldhoven, Netherlands

View Trial Details

Completed

Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer

NCT04730999

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: UOC di Oncologia Medica - AOU Policlinico S. Orsola Malpighi Bologna, Italy

UOC Oncologia Medica - PO A.Perino - ASL di Brindisi Brindisi, Italy

UOC Medicina Oncologica - Ospedale di Carpi - Azienda USL di Modena Carpi, Italy

UO di Oncologia - Istituti Ospitalieri di Cremona - ASST Di Cremona Cremona, Italy

View all 14 locations

View Trial Details

Completed

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

NCT00254384

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

Conditions: Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations: UC San Diego Moores Cancer Center San Diego, California, United States

University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States

Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

Florida Cancer Specialists Sarasota, Florida, United States

View all 18 locations

View Trial Details

Completed

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

NCT03502330

Conditions: Adenocarcinoma, Advanced Melanoma, Bronchial Neoplasms, +24 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

View Trial Details

Completed

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance

NCT00026663

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +28 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Thoracic Neoplasms

Thoracic Neoplasms trial results

Related conditions